Read More 1 minute read Analyst Ratings Initiation News Price Target Credit Suisse Initiates Coverage On Natera with Outperform Rating, Announces Price Target of $70 By Benzinga Newsdesk August 25, 5:27 AM Credit Suisse analyst Dan Leonard initiates coverage on Natera (NASDAQ:NTRA) with a Outperform rating and announces Price Target of $70. NTRA
Read More 34 minute read Earnings Earnings Scheduled For August 4, 2022 By Benzinga Insights August 4, 4:23 AM Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter. AAOI
Read More 1 minute read FDA Legal News Federal Circuit Rules In Favor Of Natera, Upholding Invalidation Of CareDx Patents By Benzinga Newsdesk July 18, 1:42 PM Natera, Inc. (NASDAQ:NTRA), a leader in personalized genetic testing and diagnostics, today announced that the Federal Circuit Court of Appeals affirmed the Delaware Federal District Court's September CDNA